Princeton BiopartnersSeparating Signal from Noise: Investment Implications in Alzheimer’s DiseaseAbstract: Alzheimer’s disease, having a large U.S. patient population, is associated with significant health and economic detriments…Jul 26Jul 26
Princeton BiopartnersLasting Legacy of COVID-19 on Clinical Trial Design and ManagementAbstract: COVID-19 appears to have been the catalyst required to overcome prior reluctance to embrace decentralized trials. In March, the…Jul 26Jul 26
Princeton BiopartnersPositioning for Value Based Care in Next Generation Immuno-TherapyAbstract: Second generation immunotherapeutics are associated with a rise in combination treatment strategies, an introduction of novel…Jul 26Jul 26
Princeton BiopartnersIntegrated Evidence Generation Planning: Transforming Biopharmaceutical Research and OutcomesDefining Integrated Evidence Generation PlanningJul 26Jul 26